Navigation Links
Cymbalta in Medical News

Lilly Reports Solid Second-Quarter 2009 Results, Raises EPS Guidance

...ing leverage and double-digit EPS growth. Sales of cymbalta and Alimta were particularly noteworthy this quart...1,239.7 (3)% $2,326.2 $2,360.0 (1)% cymbalta 744.4 654.4 14% 1,453.7 1,...rawal of generic competition in Germany. cymbalta For the second quarter of 2009,...

PatientAssistance.com Releases the Top 20 Most Popular Searches for Patient Assistance Programs

... as follows: 1. ADDERALL / ADDERALL XR (1183) 2. Lexapro (635) 3. LANTUS (556) 4. PLAVIX (533) 5. ADVAIR DISKUS (472) 6. cymbalta (412) 7. NEXIUM (390) 8. LIPITOR (389) 9. ABILIFY (361) 10. SINGULAIR (345) 11. TOPAMAX (340) 12. LISINOPRIL (333) 13. LAM...

Lilly Resubmits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration

...m, underemployment and unemployment. About cymbalta Based on preclinical studies, cymbalta is a potent reuptake inhibitor of serotonin and norepinephrine. Although the exact way that cymbalta works in people is unknown, it is believed to be r...

Surveyed Psychiatrists and PCPs Expect to Increase Their First-Line Use of SNRIs Over the Next Two Years for the Treatment of Generalized Anxiety Disorder

...ount Effexor XR's More Frequent Use in Early Lines of Therapy Compared With cymbalta WALTHAM, Mass., June 2 /PRNewswire/ -- Decision Resources, one of the ...ysis for GAD shows that Effexor XR is used more frequently than Eli Lilly's cymbalta following the failure of SSRIs in early lines of treatment. Patient-flow mo...

Lilly Reports Strong First-Quarter 2009 Results

...ithdrawal of generic competition in Germany. cymbalta For the first quarter of 2009, cymbalta generated $709.3 million in sales, an increase of ...ared with the first quarter of 2008. U.S. sales of cymbalta increased 17 percent, to $597.1 million, driven by...

How to Get Off Psychiatric Drugs Safely

... Safely, James has taken tapering off psychotropic drugs to a new level. February 23, 2009, James released six additional books titled, How to Get Off cymbalta Safely, How to Get Off Effexor Safely, How to Get Off Lexapro Safely, How to Get Off Paxil Safely, How to Get Off Prozac Safely, and How to Get Off Zo...

Lilly Reports Fourth-Quarter and Full-Year 2008 Results

...ental New Drug Application (sNDA) from the FDA for cymbalta for the management of chronic pain. The company pl...$1,273.9 (10)% $4,696.1 $4,761.0 (1)% cymbalta 721.2 628.3 15% 2,697.1 2...avorable impact of foreign exchange rates. cymbalta For the fourth quarter of 2008,...

Study Showed New Episodes of Depression Delayed in People Taking Cymbalta(R)

...ation please visit www.boehringer-ingelheim.com . P-LLY This press release contains forward-looking statements about the potential of cymbalta for the maintenance treatment of major depressive disorder, and reflects Lilly's current beliefs. However, as with any pharmaceutical product, there a...

New Webcast Going for Gold to Educate on Importance of Healthy Diet In Persistent Chronic Pain Management

... see full Prescribing Information available at http://www.ultram-er.com Paxil and Imitrex are registered trademarks of GlaxoSmithKline. Prozac and cymbalta are registered trademarks of Eli Lilly. Sarafem is a registered trademark of Warner Chilcott. Zoloft and Relpax are registered trademarks of Pfizer, I...

Cymbalta Receives European Approval for the Treatment of Generalised Anxiety Disorder

...e, Italy and Spain. In Greece, Italy and Spain Lilly markets the product as cymbalta and Boehringer Ingelheim markets the product as Xeristar(R). In the United States, cymbalta is marketed by Lilly and Quintiles. In Japan, duloxetine will be co-develop...
Cymbalta in Medical Technology

European CHMP Issues Positive Opinion on Cymbalta for the Treatment of Generalised Anxiety Disorder

INDIANAPOLIS, June 27 /PRNewswire-FirstCall/ -- Eli Lilly and Co (NYSE: LLY) and Boehringer Ingelheim today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has issued a positive opinion supporting the approval of Cymbalta(R) (dul...

Data Suggest Cymbalta Reduced Severity of Night Pain in Patients with Diabetic Nerve Pain

New Analysis Examines Impact of Pain on Sleep Interference INDIANAPOLIS, May 03, 2007 /PRNewswire-FirstCall/ -- Data from a pooled analysis of three studies suggest that in patients with pain caused by diabetic nerve damage, or diabetic peripheral neuropathy, who are treated with Cymbalta (duloxet...

Data Suggest Cymbalta Improved Functioning in Patients with Generalized Anxiety Disorder

Relationship Between Ability to Function and Treatment of Anxious and Painful Physical Symptoms Studied INDIANAPOLIS, May 21, 2007 /PRNewswire-FirstCall/ -- Data suggest that patients with generalized anxiety disorder (GAD) treated with Cymbalta(R) (duloxetine HCl) experienced improved ability to ...

Cymbalta(R) Significantly Reduced Osteoarthritis Knee Pain in New Study

...EuroQoL Questionnaire - 5 Dimension. About cymbalta Serotonin and norepinephrine in the brain a... perception of pain. Based on preclinical studies, cymbalta is a balanced and potent reuptake inhibitor of ser...and spinal cord). While the mechanism of action of cymbalta is not known in humans, scientists believe its eff...

Patients Taking Cymbalta(R) Reported Reduced Pain Severity of Osteoarthritis of the Knee in New Study

... perception of pain. Based on preclinical studies, cymbalta is a balanced and potent reuptake inhibitor of ser...and spinal cord). While the mechanism of action of cymbalta is not fully known, scientists believe its effects...nd norepinephrine in the central nervous system. cymbalta is approved in the United States for the acute and...

Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration

...ripheral neuropathic pain (DPNP) and fibromyalgia. cymbalta was studied in chronic pain of at least moderate s...perception of pain. Based on pre-clinical studies, cymbalta is a balanced and potent reuptake inhibitor of ser...and spinal cord). While the mechanism of action of cymbalta is not fully known, scientists believe its effects...

FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder

...ant clinical concern," says Doug Williamson, M.D., cymbalta associate medical director for Eli Lilly and Compa...e chance of relapse." The efficacy and safety of cymbalta for maintenance treatment of major depression was ...s in reported side effects between patients taking cymbalta compared with those taking sugar pills. Among pati...

New Data Suggest Cymbalta(R) Reduced Pain in Fibromyalgia Patients With and Without Depression

...to the U.S. Food and Drug Administration (FDA) for cymbalta for the management of fibromyalgia. The sNDA submi...e living with this debilitating condition." About cymbalta Serotonin and norepinephrine in the brain and spi...and norepinephrine in the central nervous system. cymbalta is approved in the United States for the treatment...

In New Study, Duloxetine Reduced Non-specific Pain and Emotional Symptoms Associated with Depression

...taly and Spain. In Greece, Italy and Spain Lilly will market the product as cymbalta and Boehringer Ingelheim will market the product as Xeristar®. In the United States, cymbalta is marketed by Lilly and Quintiles. In Japan, duloxetine will be co-develop...

In New Study, Duloxetine Was Equally Effective, Regardless of Switch Method, in Reducing Painful Symptoms in Ssri Non- or Partial-responders with Depression

...ment or after a change in dose. Patients taking cymbalta may experience dizziness or fainting upon standing. The most common side effects of cymbalta include: For depression: Nausea, dry mouth, hea...eece, Italy and Spain Lilly markets the product as cymbalta and Boehringer Ingelheim markets the product as Xe...
Cymbalta in Biological Technology

European CHMP Adopts Negative Opinion on Cymbalta for the Treatment of Fibromyalgia

INDIANAPOLIS, Oct. 24 /PRNewswire-FirstCall/ -- The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has adopted a negative opinion on a Cymbalta(R) (duloxetine hydrochloride) application for the treatment of fibromyalgia. "Eli Lilly and Company a...

Lilly Highlights Transformation Strategy for Wall Street, Reviews Robust Pipeline and Sets 2009 Financial Guidance

...tiple new indications and line extensions. cymbalta sales for the first three quarters have grown 28 p... U.S. and 74 percent internationally. In the U.S., cymbalta is the only established branded medicine in the an...t FDA approval for fibromyalgia. Outside the U.S., cymbalta continues to gain market share in most major inter...

US Neuropathic Pain Market Value Doubles to $5 Billion by 2018

...g with its 2007 approval for fibromyalgia, as well as the launch of Lilly's cymbalta (duloxetine) for diabetic neuropathic pain in 2004. The additional June 200...l mechanism of action. Growth will slow between 2013 and 2018 as Lyrica and cymbalta patents expire, and the fibromyalgia market penetration becomes saturated. ...

Lilly Reports Solid Second-Quarter Results

...39.7 $1,213.0 2% $2,360.0 $2,321.0 2% cymbalta 654.4 519.5 26% 1,259.5 ...sued a positive opinion supporting the approval of cymbalta for the treatment of generalized anxiety disorder (GAD). -- The FDA approved cymbalta for the management of fibromyalgia, a chronic wide...

Lilly Reports Solid First-Quarter Results

...R) $1,120.2 $1,108.0 1 % cymbalta 605.1 441.8 37 % ...rkets. Cymbalta For the first quarter of 2008, cymbalta generated $605.1 million in sales, an increase of ...ared with the first quarter of 2007. U.S. sales of cymbalta increased 32 percent, to $511.1 million, driven pr...

In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:

...oducts since December 2004. In addition, the two cymbalta studies listed in an appendix to the NEJM article ... About Cymbalta Important Safety Information cymbalta is approved to treat major depressive disorder and...few months of treatment or after a change in dose. cymbalta is approved only for adults 18 and over. ...
Other Tags
(Date:12/19/2014)... Hands On Mobile Spa, has announced they now have a ... been transformed into a utopia for the Long Island community ... The Virtual Tour showcases the beauty of the Spa On ... more. , The Virtual Tour shows viewers each of the ... overhauled Winnebago. Marla Kaplan-Pelle, Director states " It's hard to ...
(Date:12/19/2014)... December 19, 2014 After a 13-year ... is again returning to the stage to entertain his ... for concert performances, and the successful tour has been ... announced. , Visit Ticketability.com for a ... Detroit shows at fair prices. , Music fans have ...
(Date:12/19/2014)... Dec. 18, 2014 (HealthDay News) -- A new study ... moderate to severe hot flashes and night sweats -- ... Hot flashes are common during menopause, affecting about ... also affect women after menopause, since they then face ... "Our findings suggest women who exhibit moderate or severe ...
(Date:12/19/2014)... News) -- Prostaglandin analogue eye drops -- a common ... of vision loss in patients with the eye disease, ... David Garway-Heath, of the Moorfields Eye Hospital and UCL ... than 500 people newly diagnosed with open-angle glaucoma -- ... of the leading causes of blindness. About 45 ...
(Date:12/17/2014)... RI (PRWEB) December 17, 2014 ... recognize private practices that have made outstanding and ... in support and progression of private practice physical ... American Physical Therapy Association. , On behalf of ... OCS, owner and CEO of Performance accepted the ...
Breaking Medicine News(10 mins):Health News:A Virtual Tour Of Hands On Mobile Massage Spa Is Now Available 2Health News:A Virtual Tour Of Hands On Mobile Massage Spa Is Now Available 3Health News:Garth Brooks Tickets for Joe Louis Arena: Ticketability.com Becomes a Popular Destination for Discount Tickets for Garth Brooks’ Detroit Concerts Set for February 27-28 2Health News:Severe Hot Flashes During Menopause May Raise Hip Fracture Risk Later: Study 2Health News:Study Supports Benefit of Widely Used Glaucoma Drug 2Health News:Performance Physical Therapy Awarded with Jayne L. Snyder Private Practice of the Year 2014 2
(Date:12/19/2014)... LAS VEGAS , Dec. 18, 2014   ... platform built for the post-password and Internet of Things ... additional seed funding. The venture round was led by ... Pantera Capital, Rimrock Venture Partners, VegasTechFund, and others.  LaunchKey ... the new funding to expand its team and bring ...
(Date:12/17/2014)... 2014 Valencell, a leader in performance biometric ... to industry leaders such as Intel, Jabra, Atlas, and ... wearable products. These products will be showcased at CES ... Vegas . "Our partners choose ... robust – with the clinical data to back it ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has ... in the APAC Region 2015-2019"  report to their ... in this market is advances in technology. With ... upgrade biometric solutions to the latest standard that ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
Other Contents